Approval Year
| Substance Class |
Protein
Created
by
admin
on
Edited
Sat Dec 16 12:05:22 UTC 2023
by
admin
on
Sat Dec 16 12:05:22 UTC 2023
|
| Protein Sub Type | |
| Sequence Type | COMPLETE |
| Record UNII |
VH92ICR8HX
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
VH92ICR8HX
Created by
admin on Sat Dec 16 12:05:22 UTC 2023 , Edited by admin on Sat Dec 16 12:05:22 UTC 2023
|
PRIMARY |
| From | To |
|---|---|
| 1_65 | 1_298 |
| Glycosylation Type | HUMAN |
| Glycosylation Link Type | Site |
|---|---|
| N | 1_53 |
| N | 1_318 |
| N | 1_358 |
| N | 1_421 |
| N | 1_422 |
| N | 1_519 |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
INHIBITOR -> TARGET |
the Ki of PEAQX revealed it only shows a 5 fold difference in affinity for GluN1/GluN2A vs. GluN1/GluN2B receptors. It is also a potent anticonvulsant in animal tests.
COMPETITIVE ANTAGONIST
|
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| MOL_WEIGHT | CHEMICAL |
|